Abcalis Multiclonal Recombinant Secondary Antibodies
Multiclonals are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis. They consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG. Their respective epitope binding sites do not compete with each other, therefore amplifying signal strengths.
Multiclonals are useful for secondary antibody applications where a polyclonal antibody would traditionally be used and are able to provide the specificity and reproducibility only available from a recombinant antibody, making them a suitable alternative for diagnostic and research applications.
Phone: 02 9698 2022
Innovative Research Animal Biologicals
Innovative Research offers a comprehensive selection of biological products sourced from various...
EpigenTek EpiQuik CUT&RUN m6A RNA Enrichment (MeRIP) Kit
The kit is a complete set of optimised buffers and reagents designed to enrich an RNA fragment...
Cayman Chemical Off-Patent Drug Screening Library (96-Well)
Featuring a curated collection of FDA-approved compounds that are no longer covered under...
